Page 12 - LC-SFC_Pharma_Brochure
P. 12

2-2. Sample Information
            2-2. Sample Information
            Three standards of chiral compounds (bromacil, α-methyl-α-acethyl-γ-butylrolactone, and methylclothiazide) were analyzed, as shown in Fig. 2.
            These standards were prepared by dissolving in hexane and MTBE as needed at 1.0 mg/mL.

                                                                    CI
                                                                H                       O    O
                                                     CI         N
                           O         O
                                N
                                                   H2N
                                                                  N                             O
                                                                +2
                             N                        S         S
                                     Br            O         −     −
                                                       O      O   O
                             Bromacil             α-Methyl-α-Acetyl-γ-Butyloractone   Methylclothiazide
                                           Fig. 2   Structural Formulas of Analyte Chiral Compounds

            2-3. Chiral Columns
            2-3. Chiral Columns
            The iChiral-6 high-resolution polysaccharide-based columns (CHIRALPAK    the iChiral-6 columns are compatible with the range of organic sol-
                                                          ®
            IA/IB/IC/ID/IE/IF) available from Daicel Corporation were utilized to   vents specified here, these columns are applicable to method scouting
            provide the high-resolution conditions for the displayed chiral com-  analysis of chiral compounds.
            pounds. Fig. 3 shows the respective column functional groups. Since


                                                                        OR            OR
                           (A) CHIRALPAK  IA (150 mmL. × 4.6 mmI.D., 5 µm)  O          O  O
                                    ®
                            Amylose tris(3,5-dimethylphenylcarbamate)  OR  OR O n   OR  O  n
                                                                       Immobilized to   Immobilized to
                           (B) CHIRALPAK  IB (150 mmL. × 4.6 mmI.D., 5 µm)  silica gel   silica gel
                                    ®
                            Cellulose tris(3,5-dimethylphenylcarbamate)
                                                                    Amylose Derivatives  Cellulose Derivatives
                                    ®
                           (C) CHIRALPAK  IC (150 mmL. × 4.6 mmI.D., 5 µm)
                            Cellulose tris(3,5-dichlorophenylcarbamate)  R :  H          H
                                                                     N   CH 3   H        N   CH 3
                                                                                N
                                    ®
                           (D) CHIRALPAK  ID (150 mmL. × 4.6 mmI.D., 5 µm)  O  O        O
                            Amylose tris(3-chlorophenylcarbamate)      CH 3       Cl       CH 3
                                                                  (A) CHIRALPAK ®  IA  (D) CHIRALPAK ®  ID  (B) CHIRALPAK ®  IB
                                    ®
                           (E) CHIRALPAK  IE (150 mmL. × 4.6 mmI.D., 5 µm)
                                                                     H         H         H N  Cl
                            Amylose tris(3,5-dichlorophenylcarbamate)  N  Cl   N
                                                                    O         O         O
                                                                                   CH 3
                           (F) CHIRALPAK  IF (150 mmL. × 4.6 mmI.D., 5 µm)    Cl  Cl       Cl
                                    ®
                            Amylose tris(3-chloro-4-methylphenylcarbamate)  (E) CHIRALPAK ®  IE  (F) CHIRALPAK ®  IF   (C) CHIRALPAK ®  IC
                                                                         Fig. 3   Chiral Selector
            2-4. Separation Conditions
            2-4. Separation Conditions
            For the mobile phases, eight different solvent mixtures were used,   combinations and 6 different columns, the 48 unique separation
            consisting of various combinations of hexane, 2-propanol, ethanol,   conditions yielded an exhaustive search for the conditions suitable
            dichloromethane, and methyl-t-butyl ether. Details of the separation   for the separation of each of the chiral compounds.
            conditions are shown in Table 1. Using a total of 8 mobile phase
                                                   Table 1  Analytical Conditions
                   Separation Conditions     Mobile Phase          Flow Rate  Analysis Time  Other
                         No.
                          1        Hexane / 2-Propanol = 9 / 1(v/v)   3 mL/min  9 min
                          2        Hexane / 2-Propanol = 6 / 4(v/v)   3 mL/min  9 min
                          3        Hexane / Ethanol   = 8 / 2 (v/v)    3 mL/min  14 min
                          4        Ethanol                          1 mL/min   18 min   Column temperature: 40°C
                                                                                        Injection volume: 10 µL
                          5        Hexane / Dichloromethane = 9 / 1(v/v)   3 mL/min  4 min  Detection: 230 nm
                          6        Dichloromethane / Ethanol = 100 / 2(v/v)   3 mL/min  4 min
                          7        Hexane / Methyl tert-Butyl Ether = 9 / 1(v/v)  3 mL/min  4 min
                          8        Methyl tert-Butyl Ether / Ethanol = 9 / 1(v/v)   3 mL/min  4 min
                  Note: For analysis of methylclothiozide, 0.1% diethylamine was added to each mobile phase.

      2
   7   8   9   10   11   12   13   14   15   16   17